Molecular epidemiology of M. tuberculosis drug resistance in Europe

Dick van Soolingen (Nijmegen, Netherlands)

Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Disease area: Respiratory infections

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dick van Soolingen (Nijmegen, Netherlands). Molecular epidemiology of M. tuberculosis drug resistance in Europe. International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Molecular surveillance of multi-drug resistant tuberculosis in Europe
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


Molecular epidemiology of multi drug resistance tuberculosis isolates from pulmonary tuberculosis cases from Lucknow, India
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Molecular characterization of M. tuberculosis complex strains from a drug resistance survey in Albania
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013


Molecular genotyping of the clinical isolates of mycobacterium tuberculosis in Ukraine
Source: Eur Respir J 2006; 28: Suppl. 50, 848s
Year: 2006

Mycobacterium tuberculosis drug resistance surveillance in Belarus
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Recent transmission of drug resistant M. tuberculosis in Latvia
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005


Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018




Surveillance of M. tuberculosis drug resistance in Russia
Source: Eur Respir J 2001; 18: Suppl. 33, 513s
Year: 2001

Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

Molecular epidemiology of tuberculosis
Source: Eur Respir J 2002; 20: 54S-65S
Year: 2002



Molecular characterization of mycobacterium tuberculosis resistant to fluoroquinolones, distributed in Saratov region
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008


Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
Source: Eur Respir J 2010; 36: 1242-1247
Year: 2010



Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012


Structure of M. tuberculosis drug resistance in penitentiary institutions of Belarus
Source: Eur Respir J 2006; 28: Suppl. 50, 586s
Year: 2006

Secondary drug resistance tuberculosis in Iran
Source: Eur Respir J 2006; 28: Suppl. 50, 586s
Year: 2006

Standardised PCR-based molecular epidemiology of tuberculosis
Source: Eur Respir J 2008; 31: 1077-1084
Year: 2008